CompletedPHASE1, PHASE2NCT01088243

Targeting Oxidative Stress in Chronic Beryllium Disease

Studying Chronic beryllium disease

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Jewish Health
Principal Investigator: Lisa A. Maier, M.D., MSPH
National Jewish Health
Intervention: Mesalamine(drug)
Enrollment: 18 enrolled
Eligibility: 18-80 years · All sexes
Timeline: 2010 – 2015

Study locations (1)

National Jewish Health, Denver, Colorado, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01088243 on ClinicalTrials.gov

← Back to all trials